These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 313704)

  • 1. Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.
    Gazengel C; Prieur AM; Jacques C; Buriot D; Nedellec J; Josso F
    Am J Hematol; 1978; 5(4):355-63. PubMed ID: 313704
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to factor VIII-von Willebrand factor in congenital and acquired von Willebrand's disease.
    Mannucci PM; Mari D
    Prog Clin Biol Res; 1984; 150():109-22. PubMed ID: 6431422
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
    Fricke WA; Brinkhous KM; Garris JB; Roberts HR
    Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrasonic-exposed factor VIII and von Willebrand's disease].
    Casillas G; Simonetti C; Kempfer C
    Medicina (B Aires); 1981; 41 Suppl():253-6. PubMed ID: 6808289
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII/von Willebrand factor has potent lectin activity.
    Booth WJ; Furby FH; Berndt MC; Castaldi PA
    Biochem Biophys Res Commun; 1984 Jan; 118(2):495-501. PubMed ID: 6422929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA inhibitor to factor VIII/von Willebrand factor.
    Gralnick HR; Flaum MA; Kessler CM; Zimbler H; Coller BS
    Br J Haematol; 1985 Jan; 59(1):149-58. PubMed ID: 3918558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor.
    Baumgartner HR; Tschopp TB; Meyer D
    Br J Haematol; 1980 Jan; 44(1):127-39. PubMed ID: 6769457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies against the human factor VIII von Willebrand molecule: characterization and potential for screening of von Willebrand patients.
    Avner P; Arnaud D; Sultan Y; Maisonneuve P; Jeanneau C
    Dev Biol Stand; 1984; 57():69-76. PubMed ID: 6084622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of collagen with the factor VIII antigen-activity - von Willebrand factor complex.
    Nyman D
    Thromb Res; 1977 Sep; 11(3):433-8. PubMed ID: 303389
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship of the properties of antihemophilic factor (factor VIII) that support ristocetin-induced platelet agglutination (factor VIIIR:RC) and platelet retention by glass beads as demonstrated by a monoclonal antibody.
    Ogata K; Saito H; Ratnoff OD
    Blood; 1983 Jan; 61(1):27-35. PubMed ID: 6401215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitating antibodies to factor VIII/von Willebrand factor in von Willebrand's disease: effects on replacement therapy.
    Mannucci PM; Ruggeri ZM; Ciavarella N; Kazatchkine MD; Mowbray JF
    Blood; 1981 Jan; 57(1):25-31. PubMed ID: 6778538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor.
    Gouault-Heilmann M; Dumont MD; Intrator L; Chenal C; Lejonc JL
    J Clin Pathol; 1979 Oct; 32(10):1030-5. PubMed ID: 316435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Relationship between factor VIII and von Willebrand's factor in plasma and serum.
    Koutts J; Gude N; Firkin B
    Thromb Diath Haemorrh; 1975 Nov; 34(2):607. PubMed ID: 1081756
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF.
    Stibbe J
    Thromb Res; 1977 Jan; 10(1):163-8. PubMed ID: 300513
    [No Abstract]   [Full Text] [Related]  

  • 19. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.